MARYANN MATHESON: Open Payments
NPI 1285958850 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$270 in 5 payments from 3 companies in 2025. Trend: 2023 $452 · 2024 $40 · 2025 $270
Food & beverage: $270
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $162 |
| ACADIA Pharmaceuticals Inc | 1 | $91 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
Products named: REXULTI, NUPLAZID, INGREZZA.
Industry payments across TX — which companies pay providers there.
